Compare Heron Therapeutics Inc (HRTX) vs Kaltura Inc (KLTR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Heron Therapeutics Inc vs Kaltura Inc — how do they compare? Heron Therapeutics Inc trades at $0.37 (market cap $74.04M), while Kaltura Inc trades at $1.32 (market cap $202.89M). The key difference: Kaltura Inc is far larger — about 2.7× Heron Therapeutics Inc's market cap, and Kaltura Inc is trading nearer its 52-week high, Heron Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Kaltura Inc for 21 Days on average.
| HRTX | KLTR | |
|---|---|---|
Market Cap | $74.04M | $202.89M |
Volume | 3,668,095 | 214,400 |
Sector | Health | Technology |
52-Week High | $1.49 | $1.89 |
52-Week Low | $0.27 | $1.08 |
Typical Hold Time | 35 Days | 21 Days |
Enterprise Value | $180.78M | $215.11M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.39, up 17.58% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings performance discussions.
The outlook is mixed: strong analyst support and technical momentum suggest potential upside, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on revenue growth translating to profitability, while key risks include execution challenges and competitive pressures in the biotechnology sector.
Kaltura (KLTR) trades at $1.33, up 3.91% with recent earnings beats but negative profitability. Technical indicators show bearish momentum while fundamentals reveal improving margins despite net losses. The company is gaining industry recognition for AI-powered video platforms and secured major partnerships, though cash flow remains negative.
Investment outlook balances AI innovation potential against persistent financial challenges. While analyst sentiment leans positive with 44% buy ratings, high valuation multiples and negative ROE present significant risks. The stock offers speculative appeal for investors betting on AI-driven turnaround despite current unprofitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Heron Therapeutics Inc
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →About Kaltura Inc
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments: (i) Enterprise, Education, and Technology (EE&T)
Read more on KLTR →
